COBAS EGFR MUTATION TEST

Somatic Gene Mutation Detection System

FDA Premarket Approval P120019

This medical device has supplements. The device description/function or indication may have changed. Be sure to look at the supplements to get an up-to-date information on device changes. The labeling included below is the version at time of approval of the original pma or panel track supplement and may not represent the most recent labeling.

Pre-market Approval Supplement Details

Approval for the cobas® egfr mutation test. The cobas® egfr mutation test is a real-time pcr test for the qualitative detection of exon 19 deletions and exon 21 (l858r) substitution mutations ofthe epidermal growth factor receptor (egfr) gene in dna derived from formalin-fixed paraffin-embedded (ffpet) human non-small cell lung cancer (nsclc) tumor tissue. The test is intended to be used as an aid in selecting patients with metastatic nsclc for whom tarceva® (erlotinib), an egfr tyrosine kinase inhibitor (tk1), is indicated. Specimens are processed using the cobas® dna sample preparation kit for manual sample preparation and the cobas z 480 analyzer for automated amplification and detection.

DeviceCOBAS EGFR MUTATION TEST
Classification NameSomatic Gene Mutation Detection System
Generic NameSomatic Gene Mutation Detection System
ApplicantROCHE
Date Received2012-11-08
Decision Date2013-05-14
Notice Date2013-05-17
PMAP120019
SupplementS
Product CodeOWD
Docket Number13M-0594
Advisory CommitteePathology
Expedited ReviewYes
Combination Product No
Applicant Address ROCHE 4300 Hacienda Drive po Box 9002 pleasanton, CA 94588
Summary:Summary of Safety and Effectiveness
Labeling: Labeling
Approval Order: Approval Order

Supplemental Filings

Supplement NumberDateSupplement Type
P120019Original Filing
S034 2022-10-21 30-day Notice
S033
S032 2020-07-27 30-day Notice
S031
S030 2019-09-20 30-day Notice
S029 2019-06-27 Real-time Process
S028 2019-04-24 30-day Notice
S027
S026 2018-11-13 30-day Notice
S025 2018-11-09 30-day Notice
S024 2018-08-21 30-day Notice
S023 2018-07-27 30-day Notice
S022 2018-06-08 30-day Notice
S021 2018-06-04 30-day Notice
S020 2018-03-01 30-day Notice
S019 2018-02-23 Normal 180 Day Track
S018 2017-11-30 Normal 180 Day Track
S017 2017-10-30 30-day Notice
S016 2017-10-27 Normal 180 Day Track
S015 2017-09-26 30-day Notice
S014 2017-07-17 30-day Notice
S013 2017-07-14 30-day Notice
S012 2016-09-22 30-day Notice
S011 2016-08-22 30-day Notice
S010 2016-07-08 30-day Notice
S009 2016-04-18 30-day Notice
S008 2015-06-24 30-day Notice
S007 2015-05-28 Panel Track
S006 2015-03-13 30-day Notice
S005 2014-12-19 30-day Notice
S004 2013-12-13 Real-time Process
S003 2013-08-14 30-day Notice
S002 2013-08-09 30-day Notice
S001 2013-07-26 30-day Notice

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.